A citation-based method for searching scientific literature

K V S Hari Kumar, Altamash Shaikh, Pitambar Prusty. Diabetes Res Clin Pract 2013
Times Cited: 61



Tímea Varga, Anikó Somogyi, Gábor Barna, Barna Wichmann, Géza Nagy, Károly Rácz, László Selmeci, Gábor Firneisz. Pathol Oncol Res 2011
Times Cited: 39




List of shared articles



Times cited

Altered crosstalk in the dipeptidyl peptidase-4-incretin-immune system in type 1 diabetes: A hypothesis generating pilot study.
András Zóka, Gábor Barna, Orsolya Hadarits, Zahra Al-Aissa, Barna Wichmann, Györgyi Műzes, Anikó Somogyi, Gábor Firneisz. Hum Immunol 2015
3

Reduced GLP-1 response to a meal is associated with the CTLA4 rs3087243 G/G genotype.
András Zóka, Gábor Barna, Gábor Nyírő, Ágnes Molnár, László Németh, Györgyi Műzes, Anikó Somogyi, Gábor Firneisz. Cent Eur J Immunol 2019
0

Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes.
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Susana Nogueira Diniz, Andrea Fabbri, Marco Infante. Int Immunopharmacol 2021
1

Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus.
Jaquellyne Gurgel Penaforte-Saboia, Carlos Eduardo Barra Couri, Natasha Vasconcelos Albuquerque, Vanessa Lauanna Lima Silva, Natália Bitar da Cunha Olegario, Virgínia Oliveira Fernandes, Renan Magalhães Montenegro Junior. Diabetes Metab Syndr Obes 2021
1

DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Qixian Wang, Min Long, Hua Qu, Rufei Shen, Rui Zhang, Jing Xu, Xin Xiong, Hui Wang, Hongting Zheng. J Diabetes Res 2018
19

GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?
Djordje S Popovic, Edita Stokic, Stevan L Popovic. Curr Pharm Des 2015
4